XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2019
Operating activities    
Net loss $ (5,132,914) $ (6,781,161)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 16,291 27,569
Stock-based compensation 486,120 491,749
Non-cash interest on convertible notes 152,045 51,333
Non-cash discount amortization on short-term notes and convertible notes 611,020 233,224
Revaluation of premium conversion derivatives (371,831) 111,195
Revaluation of warrant liability 35,235 18,568
Loss on note extinguishments 1,314,487 553,447
Change in assets and liabilities:    
Prepaid and other assets 1,768 (35,624)
Accounts payable and accrued expenses 658,572 (66,257)
Net cash used in operating activities (2,229,207) (5,395,957)
Investing activities    
Purchase of intangible assets (55,000) (65,000)
Purchase of property and equipment (58,352)
Net cash used in investing activities (55,000) (123,352)
Financing activities    
Proceeds from issuance of convertible promissory notes 432,849
Proceeds from issuance of warrants associated with convertible notes 442,151
Proceeds from issuance of common stock in connection with private placement 824,894 4,561,215
Proceeds from issuance of warrants in connection with private placement 288,106 1,709,233
Issuance costs in connection with private placement (689,494)
Exercise of warrants 416,333
Exercise of stock-options 52,511
Proceeds from unsecured loans 283,000 245,000
Repayment of unsecured loans (528,000)
Net cash provided by financing activities 2,271,000 5,766,798
Net increase (decrease) in cash (13,207) 247,489
Cash at beginning of period 26,467 13,260
Cash at end of period 13,260 260,749
Supplemental non-cash financing and investing transactions:    
Conversion of short term notes and convertible promissory notes to equity 2,063,361 1,678,361
Exercise of premium conversion derivative liability 419,590
Reclassification of warrant liability to equity 835,723
Bifurcation of premium conversion derivative related to convertible notes 168,384
Issuance of additional warrants in connection with short-term notes and convertible promissory notes modifications 829,378
Change in accounts payable and accrued expenses attributed to private placement and convertible note issuance costs 175,917 100,347
Non-cash issuance of broker warrants in connection with private placements 378,838
Stock-based compensation liability reclassification to equity $ 11,153